From evidence to best practice in laboratory medicine

Clinical Biochemist Reviews

Volumn 34, Issue 2, 2013, Pages 47-60

  Horvath, A Rita ^a,b,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84902013326     PISSN: 01598090     EISSN: 18380212     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Ferrante di Ruffano L, Hyde CJ, McCaffery KJ, Bossuyt PM, Deeks JJ. Assessing the value of diagnostic tests: a framework for designing and evaluating trials. BMJ 2012;344:e686.
2. Stillman AE, Woodard PK; RESCUE Investigators. Consequence of overuse of invasive coronary angiography. Arch Intern Med 2011;171:709, author reply 709-10.
3. Gray JAM. Evidence-Based Health Care: How to Make Health Policy and Management Decisions. London: Churchill Livingstone; 1997.
4. Ioannidis JP. Biomarker failures. ClinChem 2013;59:202-4.
5. Bates DW, Kuperman GJ, Wang S, Gandhi T, Kittler A, Volk L, et al. Ten commandments for effective clinical decision support: making the practice of evidence-based medicine a reality. J Am Med Inform Assoc, 2003; 10:523-30.
6. Munro J, Booth A, Nicholl J. Routine preoperative testing: a systematic review of the evidence. Health Technol Assess 1997;l:i-iv,l-62.
7. Prochazka AV, Caverly T. General health checks in adults for reducing morbidity and mortality from disease: summary review of primary findings and conclusions. JAMA Intern Med, 2013;173:371-2.
8. Kroenke K. Diagnostic testing and the illusory reassurance of normal results: comment on "Reassurance after diagnostic testing with a low pretest probability of serious disease". JAMA Intern Med, 2013;173:416-7.
9. Brown RD, Langshaw MR, Uhr EJ, Gibson JN, Joshua DE. The impact of mandatory fortification of flour with folic acid on the blood folate levels of an Australian population. Med J Aust, 2011;194:65-7.
10. Australian Government Department of Health and Ageing. MBS Review: Vitamin B12/Folate Testing Protocol. January 2013.
11. MoynihanR, Doust J, Henry D. Preventing overdiagnosis: how to stop harming the healthy. BMJ 2012;344:e3502.
12. Winearls CG, Glassock RJ. Classification of chronic kidney disease in the elderly: pitfalls and errors. Nephron ClinPract 201l;119(SUPPL 1):c2-4.
13. Sandhu GS, Andriole GL. Overdiagnosis of prostate cancer. J Natl Cancer Inst Monogr, 2012;2012:146-51.
14. McGlynn EA, Asch SM, Adams J, Keesey J, Hicks J, DeCristofaro A, et al. The quality of health care delivered to adults in the United States. N Engl J Med, 2003;348:2635-45.
15. Marcelino JJ, Feingold KR. Inadequate treatment with HMG-CoA reductase inhibitors by health care providers. Am J Med, 1996;100:605-10.
16. HinH, BirdG, FisherP,MahyN, JewellD. Coeliac disease in primary care: case finding study BMJ 1999;318:164-7.
17. Vilppula A, Collin P, Maki M, Valve R, Luostarinen M, Krekela I, et al. Undetected coeliac disease in the elderly: a biopsy-proven population-based study. Dig Liver Dis, 2008;40:809-13.
18. Neil HA, Hammond T, Huxley R, Matthews DR Humphries SE. Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry study. BMJ, 2000; 321:148.
19. Frost M, Wraae K, Gudex C, Nielsen T, Brixen K, Hagen C, et al. Chronic diseases in elderly men: underreporting and underdiagnosis. Age Ageing, 2012;41:177-83.
20. Scherer LD, Zikmund-Fisher BJ, Fagerlin A, Tarini BA. Influence of "GERD" label on parents' decision to medicate infants. Pediatrics, 2013;131:839-45.
21. Fryer AA, Hanna FW. Managing demand for pathology tests: financial imperative or duty of care? Ann Clin Biochem 2009;46:435-7.
22. Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, van der Meulen JH, et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA, 1999;282:1061-6.
23. Tzoulaki I, Siontis KC, Evangelou E, Ioannidis JP. Bias in associations of emerging biomarkers with cardiovascular disease. JAMA Intern Med, 2013;173:664-71.
24. Svensson S, Menkes DB, Lexchin J. Surrogate outcomes in clinical trials: a cautionary tale. JAMA Intern Med, 2013;173:611-2.
25. Mickan S, Burls A, Glasziou P. Patterns of 'leakage' in the utilisation of clinical guidelines: a systematic review. Postgrad Med J, 2011;87:670-9.
26. Schleifer D, Rothman DJ. "The ultimate decision is yours": exploring patients' attitudes about the overuse of medical interventions. PLoS One 2012;7:e52552.
27. Rolfe A, Burton C. Reassurance after diagnostic testing with a low pretest probability of serious diseasesy stematic review and meta-analysis. JAMA Intern Med, 2013;173:407-16.
28. Redberg R, Katz M, Grady D. Diagnostic tests: another frontier for less is more: or why talking to your patient is a safe and effective method of reassurance. Arch Intern Med 2011;171:619.
29. Power M, Fell G, Wright M. Principles for high-quality, high-value testing. Evid Based Med, 2013;18:5-10.
30. Wise J. Boldt: the great pretender. BMJ 2013;346:fl738.
31. Field MJ,LohrKN (Eds). Guidelines for Clinical Practice: From Development to Use. Institute of Medicine, Washington DC: National Academy Press; 1992.
32. Fixsen DL, Naoom SF, Blase KA, Friedman RM, Wallace F. Implementation Research: A Synthesis of the Literature. FMHI Publication #231. Tampa, FL: University of South Florida, Louis de la Parte Florida Mental Health Institute, The National Implementation Research Network; 2005.
33. Chaudoir SR Dugan AG, Barr CH. Measuring factors affecting implementation of health innovations: a systematic review of structural, organizational, provider, patient, and innovation level measures. Implement Sci, 2013; 8:22.
34. CockburnJ. Adoptionof evidence into practice: canchange be sustainable? Med J Aust 2004;180(SUPPL):S66-7.
35. Green LA, Seifert CM. Translation of research into practice: why we can't "just do it". J Am Board Fam Pract, 2005;18:541-5.
36. National Health and Medical Research Council. A guide to the development, implementation and evaluation of clinical practice guidelines. Canberra: NHMRC, Commonwealth of Australia; 1999.
37. National Health and Medical Research Council. How to put the evidence into practice: implementation and dissemination strategies. Handbook series on preparing clinical practice guidelines. Canberra: NHMRC, Commonwealth of Australia; 2000.
38. Kiefe CI, Sales A. A state-of-the-art conference on implementing evidence in health care. Reasons and recommendations.(Editorial)JGen Intern Med 2006;21(SUPPL2):S67-70.
39. Janssens PM. Managing the demand for laboratory testing: options and opportunities. Clin Chim Acta, 2010;411:1596-602.
40. Scott A, Sivey P, Ait Ouakrim D, Willenberg L, Naccarella L, Furler J, et al. The effect of financial incentives on the quality of health care provided by primary care physicians. Cochrane Database Syst Rev 2011;(9):CD008451.
41. Guideline on Pathology Testing in the Emergency Department. Australasian College for Emergency Medicine Guideline G125. Royal College of Pathologists of Australasia Document 1/2013. http://www.acem.org.au/media/RCPA_ACEM_Guideline_v01__Mar-13__Final.pdf (Accessed 14 May 2013).
42. National Coalition of Public Pathology. Encouraging Quality Pathology Ordering in Australia's Public Hospitals. Final Report, February 2012. http://www.ncopp.org.au/site/quality_use.php (Accessed 14 May 2013).
43. Osborn CY, Mayberry LS, Mulvaney SA, Hess R. Patient web portals to improve diabetes outcomes: a systematic review. CurrDiab Rep, 2010;10:422-35.
44. National Collaborating Centre for Acute Care. The use of routine preoperative tests for elective surgery. Clinical Guideline 3. National Institute for Health and Clinical Excellence. 2003. http://www.nice.org.uk/nicemedia/ pch7CG3NICEguideline.pdf (Accessed 14 May 2013).
45. Czoski-Murray C, Lloyd Jones M, McCabe C, Claxton K, Oluboyede Y, Roberts J, et al. What is the value of routinely testing full blood count, electrolytes and urea, and pulmonary function tests before elective surgery in patients with no apparent clinical indication and in subgroups of patients with common comorbidities: a systematic review of the clinical and cost-effective literature. Health Technol Assess 2012;16:i-xvi,1-159.
46. Queensland Health Pathology and Scientific Services AUSLAB Retest Interval Project. Final Project Report, December 2004.
47. Driskell OJ, HollandD, HannaFW, Jones PW, Pemberton RJ, Tran M, et al. Inappropriate requesting of glycated hemoglobin (Hb Ale) is widespread: assessment of prevalence, impact of national guidance, and practice-to-practice variability. Clin Chem, 2012;58:906-15.
48. Main C, Moxham T, Wyatt JC, Kay J, Anderson R Stein K. Computerised decision support systems in order communication for diagnostic, screening or monitoring test ordering: systematic reviews of the effects and cost-effectiveness of systems. Health Technol Assess, 2010;14:1-227.
49. Shojania KG, Jennings A, Mayhew A, Ramsay CR Eccles MP, Grimshaw J. The effects of on-screen, point of care computer reminders on processes and outcomes of care. Cochrane Database Syst Rev 2009;3,CD001096.
50. Arditi C, Rege-Walther M, Wyatt JC, Durieux P, Burnand B. Computer-generated reminders delivered on paper to healthcare professionals; effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2012;12:CD001175.
51. Matheny ME, Sequist TD, Seger AC, Fiskio JM, Sperling M, Bugbee D, et al. A randomized trial of electronic clinical reminders to improve medication laboratory monitoring. J Am Med Inform Assoc, 2008;15:424-9.
52. Levick DL, Stern G, Meyerhoefer CD, Levick A, Pucklavage D. "Reducing unnecessary testing in a CPOE system through implementation of a targeted CDS intervention". BMC Med Inform Decis Mak, 2013; 13:43.
53. Zaat JO, van Eijk JT, Bonte HA. Laboratory test form design influences test ordering by general practitioners in The Netherlands. Med Care, 1992;30:189-98.
54. van Walraven C, Goel V, Chan B. Effect of population-based interventions on laboratory utilization: a time-series analysis. JAMA, 1998;280:2028-33.
55. Barth JH, Balen AH, Jennings A. Appropriate design of biochemistry request cards can promote the use of protocols and reduce unnecessary investigations. Ann Clin Biochem, 2001;38:714-6.
56. Bailey J, Jennings A, Parapia L. Change of pathology request forms can reduce unwanted requests and tests. J Clin Pathol, 2005;58:853-5.
57. Smellie WS; Association for Clinical Biochemistry's Clinical Practice Section. Time to harmonise common laboratory test profiles. BMJ 2012;344:el 169.
58. Fryer A A, Smellie WS. Managing demand for laboratory tests: a laboratory toolkit. J Clin Pathol, 2013;66:62-72.
59. Skeie S, Perich C, Ricos C, Araczki A, Horvath AR, Oosterhuis WP, et al. Postanalytical external quality assessment of blood glucose and hemoglobin Ale: an international survey. Clin Chem, 2005;51:1145-53.
60. Aakre KM, Thue G, Subramaniam-Haavik S, Bukve T, Morris H, Muller M, et al. Postanalytical external quality assessment of urine albumin in primary health care: an international survey. Clin Chem, 2008;54:1630-6.
61. Willis E A, Datta BN. Effect of an educational intervention on requesting behaviour by a medical admission unit. Ann Clin Biochem, 2013;50:166-8.
62. The AGREE Next Steps Consortium. Appraisal of Guidelines for Research & Evaluation II. AGREE II instrument. May 2009. http://www.agreetrust.org/wp-content/uploads/2013/06/AGREE_II_Users_Manual_and_23-item_Instrument_ENGLISH.pdf (Accessed 14 May 2013).
63. Hsu J, Brozek JL, Terracciano L, Kreis J, Compalati E, Stein AT, et al. Application of GRADE: making evidence-based recommendations about diagnostic tests in clinical practice guidelines. Implement Sci, 2011; 6:62.
64. National Institute of Clinical Studies. Assessing the implementability of guidelines. Melbourne: NICS; 2006.
65. Shiffman RN, Dixon J, Brandt C, Essaihi A, Hsiao A, Michel G, et al. The GuideLine Implementability Appraisal (GLIA): development of an instrument to identify obstacles to guideline implementation. BMC Med Inform Decis Mak, 2005; 5:23.
66. Davey RX. Troponin reporting in Australia in 2003. Ann Clin Biochem, 2005;42:61-3.
67. Ungerer JP, Marquart L, O'Rourke PK, Wilgen U, Preterms CJ. Concordance, variance, and outliers in 4 contemporary cardiac troponin assays: implications for harmonization. Clin Chem, 2012;58:274-83.
68. Cheung NW, Conn JJ, d'Emden MC, Gunton JE, Jenkins AJ, Ross GP, et al. Australian Diabetes Society Position Statement: Individualization of HbAlc targets for adults with diabetes mellitus. September 2009. http://www.diabetessociety.com.au/downloads/positionstatements/HbAlctargets.pdf (Accessed 9 July 2013).
69. Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol, 2008;103:1541-9.
70. Heneghan C, Ward A, Perera R, Bankhead C, Fuller A, Stevens R, et al; Self-Monitoring Trialist Collaboration. Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data. Lancet 2012;379:322-34.